[Paclitaxel containing chemotherapeutic regimens in first line and reintroduced palliative treatment of metastatic cervical cancer]. / Paklitaxeltartalmú kemoterápiás kombináció metasztatikus cervixtumor elso vonali és reindukciós palliatív kezelésében.
Orv Hetil
; 159(24): 974-977, 2018 Jun.
Article
em Hu
| MEDLINE
| ID: mdl-29888659
ABSTRACT
INTRODUCTION:
The paclitaxel-carboplatin doublet is an alternative choice in the first line treatment of metastatic or recurrent cervical cancer according to international guidelines.METHOD:
The history of seven patients treated with paclitaxel-platinum in the last three years in the Petz Aladár Hospital is reported. A case report, supporting the efficacy of the combination in emergency and in reintroduced settings is presented as well.RESULTS:
The average progression-free survival was 10 months. All patients were alive at the time of the submission of the article.CONCLUSION:
The results confirm the efficacy of the paclitaxel-carboplatin AUC 5 and the paclitaxel-cisplatin combinations in the treatment of metastatic cervical cancer. Orv Hetil. 2018; 159(24) 974-977.Palavras-chave
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Cuidados Paliativos
/
Protocolos de Quimioterapia Combinada Antineoplásica
/
Neoplasias do Colo do Útero
/
Carboplatina
/
Paclitaxel
Tipo de estudo:
Guideline
Limite:
Adult
/
Aged
/
Female
/
Humans
/
Middle aged
Idioma:
Hu
Ano de publicação:
2018
Tipo de documento:
Article